Sarepta Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
215 1st St, Cambridge, Massachusetts, 02...Phone Number
(617) 274-4000Website
www.sarepta.comRevenue
$2.2 BillionStock Symbol
SRPTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
7
1
1
1
2
1
About Sarepta Therapeutics
Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.Explore more
Sarepta Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sarepta Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sarepta Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Sarepta Therapeutics launches new products
Check if Sarepta Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Sarepta Therapeutics is spiking on competitors!
Sarepta Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sarepta Therapeutics recently announced quarterly report
Click to see if Sarepta Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sarepta Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Sarepta Therapeutics
Compare insights from companies similar to Sarepta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sarepta Therapeutics
$2.2B
501-1,000
Public
$2.8B
1980
ZG
Zohal GhiaszadaSenior Director, Chief of Staff To Chief Medical and Regulatory Officer
$675.1M
1K - 5K
Private
$225M
2009
LM
Leslie MillingtonSenior Director, Business Strategy & Operations Chief of Staff
Company Profile Activity
Activity Insights
Sarepta Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sarepta Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sarepta Therapeutics.
Sarepta Therapeutics financials insights
Gather financial insights about Sarepta Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Stock Offering
$125M
2014
Stock Offering
$94.5M
2015
Stock Offering
$127M
2016
Stock Offering
$300M
2017
Multiple Rounds
$900M
2018
Stock Offering
$500M
2019
Multiple Rounds
$655.5M
Sarepta Therapeutics Tech Stack
A closer look at the technologies used by Sarepta Therapeutics
See more technologies
Most Recent Scoops
Hiring Plans
Sarepta Therapeutics has more open roles in Finance than it has had at any time in the past 6 months. Areas of expertise include: Cross-Functional Collaboration, Cross-Functional Team Leadership, Operationalization, International Standards, Governance, Compliance Implementation, and Lifecycle Management.
Hiring Plans
Open Position
Hiring Plans
Sarepta Therapeutics has more open roles in Human Resources than it has had at any time in the past 12 months.
Hiring Plans
Project
Sarepta Therapeutics has announced that Roche has initiated a new global Phase III trial for ELEVIDYS outside the United States, following scientific advice from the EMA and CHMP.
Clinical Operations
Open Position
Sarepta Therapeutics News & Media
Improving Profitability Supports Sarepta Therapeutics Inc. (SRPT) as One of the Most Shorted Small-Cap Stocks to Buy
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 6, Sarepta Therapeutics Inc. (NASDAQ:SRPT) delivered impressive first-quarter results as it bounced back to profitability despite facing commercialization challenges with its flagship gene therapy, ELEVIDYS. Total revenue in the quarter was $730.8 million, a decrease of […]In Solid Cash Position, Sarepta Therapeutics Inc (SRPT) Outlines 2026 Priorities
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. 36 elite hedge funds have positions in Sarepta Therapeutics Inc (NASDAQ:SRPT) stock, and analysts on the Street expect this gene therapy stock to pop at least 28% from its current level. On May […]My Top 3 Biotech Stocks for May 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.Why Elevidys Matters For Sarepta Therapeutics Inc (SRPT) Stock
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the best gene therapy stocks to buy in 2026. Sarepta’s Q1 2026 report, released on May 6, showed that both earnings and revenue surpassed analysts’ expectations. Adjusted EPS of $3.16 smashed the expectation of $0.99, and revenue of $730.8 million exceeded the anticipated $474.3 million. During the quarter, […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sarepta Therapeutics
Sign Up For FreeTo access detailed company insights
Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscu... Read More
